Prof. Dr. med. Carola Berking

Lehrstuhl für Haut- und Geschlechtskrankheiten

One set to collect them all? The development of a core domain set for medium-to-giant congenital melanocytic naevi (2021) Heppt M, Steeb T, Berking C Journal article Online consensus conferences for the development and update of clinical practice guidelines: A survey among participants of the German S3 guideline on actinic keratosis and cutaneous squamous cell carcinoma (2021) Steeb T, Follmann M, Langer T, Nothacker M, Wessely A, Garbe C, Leiter U, et al. Journal article Experiences of In-Patients with Skin Cancer in a German University Hospital Setting: A Cross-Sectional Survey (2021) Steeb T, Wessely A, Merkl H, Voskens C, Erdmann M, Heinzerling L, Berking C, Heppt M Journal article Surveillance of patients with conjunctival melanoma in German-speaking countries: A multinational survey of the German dermatologic cooperative oncology group (2021) Wessely A, Steeb T, Berking C, Schlaak M, Heppt M, Alter M, Bayerl C, et al. Journal article Implications of the COVID-19 Pandemic for the Development and Update of Clinical Practice Guidelines: Viewpoint (2020) Steeb T, Follmann M, Hagen RM, Berking C, Heppt M Journal article Immune checkpoint blockade in advanced cutaneous squamous cell carcinoma: What do we currently know in 2020? (2020) Wessely A, Steeb T, Leiter U, Garbe C, Berking C, Heppt M Journal article Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion (2020) Simon D, Tascilar K, Krönke G, Kleyer A, Zaiss M, Heppt F, Meder C, et al. Journal article Patient Perception of Mobile Phone Apps for the Care and Prevention of Sexually Transmitted Diseases: Cross-Sectional Study (2020) Jakob L, Steeb T, Fiocco Z, Pumnea T, Jakob SN, Wessely A, Rothenberger CC, et al. Journal article The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology (2020) Reinholz M, French LE, Berking C, Heppt M Journal article, Letter Patients Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 Infection (2020) Simon D, Tascilar K, Krönke G, Kleyer A, Zaiss M, Heppt F, Meder C, et al. Conference contribution